Otolaryngology Doctors in Topeka, KS Accepting Medicare

9 Otolaryngology doctors found. Showing 1 - 9

Jason Lepse, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 920 Sw Lane St Ste 200, Topeka, KS 66606 Phone: 785-233-0500

Dr. Matthew David Glynn, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sw Lane St, Suite 200, Topeka, KS 66606 Phone: 785-233-0500    Fax: 785-233-0660

Dr. Douglas Edward Barnes, MD FACS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sw Lane St, Suite 200, Topeka, KS 66606 Phone: 785-233-0500    Fax: 785-233-0660

Dr. Scot David Hirschi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sw Lane St, Suite 200, Topeka, KS 66606 Phone: 785-233-0500    Fax: 785-233-0660

Tyler Curtis Grindal, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sw Lane St, Suite #200, Topeka, KS 66606 Phone: 785-233-0500    Fax: 785-233-0660

Jason A Meyers, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sw Lane St Ste 200, Topeka, KS 66606 Phone: 785-233-0500    Fax: 785-233-0660

Dr. Fredric B Gnau, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Topeka, KS 66622 Phone: 785-350-3111

Dr. Robert Viron Lane, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sw Lane St, Suite #200, Topeka, KS 66606 Phone: 785-233-0500    Fax: 786-233-0660

Dr. Michael Douglas Franklin, MD FACS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sw Lane St, Suite # 200, Topeka, KS 66606 Phone: 785-233-0500    Fax: 785-233-0660

News Archive

Clinical study shows how EarlySense system effectively detects opioid-induced respiratory depression

EarlySense, the market leader in contact-free continuous monitoring solutions across the care continuum, today announced that its system has been found to detect and alert for respiratory depression with high positive predictive value, according to a clinical poster presented at the 2018 American Thoracic Society Conference.

Advaxis awarded $210,000 for development of a dual antigen vaccine

Advaxis, Incorporated (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, has been awarded a $210,000 grant from the US National Institute of Health (NIH) to develop a single bioengineered Lm vaccine to deliver two different antigen-adjuvant proteins.

Researchers spot molecular key that breast cancer cells use to invade bone marrow

Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise eradicate them.

School Health honors Cardiac Science with prestigious Top Partner of the Year award

Fighting sudden cardiac arrest (SCA) in schools has been a business and social imperative for Cardiac Science since the company's founding. The reason is clear: Studies show that one in 50 high schools has had a SCA incident–either student or faculty–on school grounds each year–according to Parent Heart Watch, a CPR/AED Advocacy Group.

Genetic variants impact outcome in dilated cardiomyopathy patients of African ancestry

Genetic testing is a powerful diagnostic tool that is increasingly being used for the diagnosis of dilated cardiomyopathy, a disease in which the heart becomes enlarged, making it difficult to pump blood. Cardiomyopathy affects more than 3.5 million people in the United States.

Read more Medical News

› Verified 8 days ago